The latest news from academia, regulators
research labs and other things of interest
Posted: December 3, 2008
ADA Technologies Receives Grant for Cancer Nanotechnology Research
(Nanowerk News) ADA Technologies, Inc. (ADA) received a $149,121 grant from the National Cancer Institute* for research and development of nanotechnology imaging and sensing platforms for improved detection and diagnosis of cancer.
ADA’s research focuses on developing a nano-enabled sensing platform for analysis of biomolecules, such as cancer biomarkers, that is more sensitive than existing technologies. Analysis platforms that provide high sensitivity and high throughput are critical to cancer biomarker detection.
“Our research will provide the scientific and medical communities with a reliable, ready-to-use platform that is capable of detecting multiple biomolecules to facilitate cancer biomarker screening and improve cancer diagnosis,” said Xichun Zhou, ADA principal investigator.
ADA’s R&D efforts related to nanotechnology imaging and sensing platforms began in 2007.
*This project is wholly funded with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261200800061C.
About ADA Technologies, Inc.
ADA Technologies, Inc. is a research, development, and commercialization company that specializes in creating and converting innovative technologies to commercial successes. The firm is headquartered in Littleton, Colorado, with offices on the University of Wyoming campus in Laramie and the Virginia Tech Corporate Research Center, Blacksburg, VA. ADA has received more than 130 research grants totaling more than $40 million. ADA has received numerous honors, including: 2006 Tibbetts Award, 2006, 2007 & 2008 Colorado Technology Fast 50, 2006 & 2007 Best Companies to Work For in Colorado and Colorado’s Top Technology Company 2005. For more information, please visit www.adatech.com or call 303-792-5615.